Notice2026-11822
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 12, 2026
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 113 (Friday, June 12, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 113 (Friday, June 12, 2026)]
[Notices]
[Page 35689]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-11822]
[[Page 35689]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-26-1406]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Traveler-based Genomic Surveillance (TGS)''
to the Office of Management and budget (OMB) for review and approval.
CDC previously published a ``Proposed Data Collection Submitted for
Public Comment and Recommendations'' notice on January 13, 2026, to
obtain comments from the public and affected agencies. CDC received
four comments related to the previous notice. This notice serves to
allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a> Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Traveler-based Genomic Surveillance (TGS) (OMB Control No. 0920-
1406, Exp. 6/30/2026)--Revision--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The goal of CDC's Traveler-based Genomic Surveillance (TGS) program
is to monitor for communicable diseases among arriving international
air travelers at select U.S. airports. The TGS program enables the
early detection of communicable disease importations of public health
concern and fills gaps in global biosurveillance by monitoring trends
in global circulation of communicable diseases. Travelers who volunteer
to participate in the program at the airport and provide written,
informed consent complete a short, anonymous questionnaire asking for
travel information and general demographics. Participants then self-
collect two lower nasal swab samples. One swab is pooled with other
traveler swabs in batches of 5-10 samples. Pooled samples undergo
initial testing for pathogens of public health importance (including
SARS-CoV-2, Influenza A virus, and RSV [respiratory syncytial virus])
via reverse transcription polymerase chain reaction (RT-PCR) testing.
If any pool of swabs registers with any positive test, then all
secondary swab samples (stored individually) corresponding to those in
the pool are tested individually. Pathogen genomic sequencing may be
performed on samples to determine the pathogen lineage. Some samples
may be sent to CDC for further testing. No human genetic testing will
be performed.
This request is a Revision of the approved collection request
titled: Traveler-based Genomic Surveillance (OMB Control No. 0920-
1406). The program has since broadened to include testing nasal swabs
for pathogens beyond SARS-CoV-2. The program has also streamlined the
questions asked of participants based on data from previous versions of
the questionnaire, participant feedback received through program staff
at the airports, and direct input from the program staff at the
airports. The updated information collection has fewer questions, and
question wording has been tailored to improve participant comprehension
and response rates.
CDC requests OMB approval for an estimated 26,667 annualized burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Inbound international air travelers... TGS Participant 400,000 1 4/60
Questionnaire.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2026-11822 Filed 6-11-26; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on June 12, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.